Product INN: Furaginum solubile
Deva: 25 mg capsules; 50 mg capsules
Product ATC Code: J01XE
Furamag is used in the treatment of urinary tract infectious diseases caused by microorganisms susceptible to furagin soluble (cystitis, urethritis, pyelonephritis); prostatitis, gynecological infections.
For prophylaxis it may be used in cases of urological surgery, cystoscopy, catheterisation and also for prophylaxis of urinary tract infections relapse.
Product Mechanism of Action
The active component of the preparation Furamag - furagin soluble possesses high antibacterial activity and a broad spectrum of action. The drug is active against both gram-positive and gram-negative microorganisms. Resistance against active substance develops slowly and does not reach a high level. Compared to other derivatives of nitrofuran, furagin soluble is more active against Staphylococci as well as many other pathogenic and relative pathogenic microorganisms (Escherichia coli, Aerobacter aerogenes, Bacterium citrovorum, Proteus mirabilis, Proteus morganii, Staphylococcus aureus, S. saprophyticus, S. epidermidis, Streptococcus agalactiae, Enterococcus group streptococci: Enterococcus faecalis, Enterococcus faecium un Corynebacterium); active also against different gram-negative bacteria including Citrobacter amalonaticus, C. diversus, C. freundii, Klebsiella oxytoca, K. ozaenae, Enterobacter, Escherichia coli, Neisseria, Salmonella, Shigella.
It is inactive against the largest part of Proteus, Serratia and Pseudomonas strains.
Minimal inhibitory concentration (MIC) of Furamag in vitro for the most sensitive organisms is from 0.2 to 6 mcg/ml. According to the international standards MIC of nitrofuran derivatives for sensitive microorganisms is to 32 mcg/ml, for average sensitive MIC is from 32 to 64 mcg/ml, but for resistant - 64 to 128 mcg/ml.
The medicine is taken orally after meals. Capsules should be swallowed unbroken, with plenty of liquid.
Adults are indicated 50 mg to 100 mg 3 times per day.
Children with body weight over 30 kg – 50 mg 3 times per day.
Duration of the treatment course is 7 to 10 days. If necessary, the course may be repeated after 10 to 15 days.
Adults and children with body weight over 30 kg – 50 mg before bedtime.
Medicines unreasonable use is harmful to health.